GlassScriptPhysician profile
Keith M Rezin
NPI 1407867393
$781.19
in general payments reported to CMS, 2019-2025
20 companies · $16.64 in 2025
The $16.64 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $151 · 2021: $137 · 2023: $173 · 2024: $36.61 · 2025: $16.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $226.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $207.40 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $73.41 | 2020 | |
| Sanofi-Aventis U.S. LLC | $71.51 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $60.14 | 2023-2024 | Bridion |
| Mallinckrodt Enterprises LLC | $53.48 | 2019 | |
| Smith+Nephew, INC. | $42.20 | 2023-2024 | Pico 14, Acticoat 4" X 4", Pico |
| Djo, LLC | $35.73 | 2023-2025 | Cmf |
| Pacira Pharmaceuticals Incorporated | $34.68 | 2021 | |
| Organogenesis INC. | $23.66 | 2021 | |
| Integra Lifesciences Corporation | $23.21 | 2019 | |
| Misonix INC | $19.62 | 2019 | |
| Horizon Therapeutics Plc | $19.35 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.10 | 2021 | |
| Medline Industries LP | $16.58 | 2023 | |
| Stryker Corporation | $15.45 | 2023 | Crossfire |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $15.12 | 2019 | |
| Molnlycke Health Care US, LLC | $14.47 | 2021 | |
| Bioventus LLC | $13.08 | 2019 | |
| Philips North America LLC | $12.94 | 2019 | |
| Medela LLC | $12.06 | 2023 | Invia Motion Endure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Rezin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.